As one of the great popular actors of our time, Harrison Ford, is much admired by filmgoers in Taiwan and overseas. However, in a Ford-produced movie that sees him playing the role of a Midwestern medical researcher looking for a cure for a rare muscle disease, released earlier this year in theaters in the US and now worldwide on DVD, titled Extraordinary Measures, Ford neglected to give credit to the actual scientist who found the cure for Pompe Disease — Chen Yuan-tsong (陳垣崇) of Taiwan.
Chen did the original research that led to finding the cure in the 1990s while he was at Duke University in North Carolina. A writer for the Wall Street Journal, Geeta Annand, wrote a series of newspaper articles about the search for the cure and later turned her stories into a book titled The Cure.
Ford bought the film rights to the book, asked his scriptwriters to turn Chen into a white lab scientist named Dr Stonehill and completely left any mention of Chen’s work out of the picture. Not one part of the movie’s dialog mentions Chen’s name at all and even the opening and closing credits fail to mention the doctor’s name.
Ford and the Hollywood studio that bankrolled the movie need to explain themselves. Sure, movies are movies and Hollywood is Hollywood, but to take the real-life medical work of a Taiwanese scientist and turn it into a Hollywood medical thriller “inspired by true events” that does even mention the name of the man who inspired the movie is an affront to medical researchers everywhere.
When Chen recently attended a press conference on the sidelines of the release of the DVD version of the movie, the Central News Agency (CNA) in Taipei reported that he had “mixed feelings” about the movie.
When this reporter recently asked Chen to explain his feelings about the movie, he told me: “What the movie failed to show was who actually developed the drug that the characters Megan and Patrick in the film eventually received. There were many scientists behind the scenes that helped to find the cure.”
However, Chen was gracious in his remarks, adding: “However, I still appreciate Harrison Ford bringing the Pompe story to movie audiences worldwide. This kind of Hollywoodized medical drama helps create public awareness of rare devastating diseases such as Pompe, and hopefully the film will create support channels for helping those children who suffer from Pompe and their families.”
Despite Hollywood’s neglect, Chen is now being recognized in Taiwan for his medical research on Pompe Disease.
“Regardless of how Hollywood decided to recast Chen, his contribution to helping find the cure is well established,” CNA said. “He developed the treatment with colleagues at Duke University Medical Center. His R&D was mostly done in the United States, but Chen conducted his clinical trials for the cure — later named Myozyme — in Taiwan, at National Taiwan University Hospital.”
“Myozyme, which took Chen and his team 15 years to research and develop, was introduced in Taiwan by US pharmaceutical company Genzyme and included as a drug covered by Taiwan’s National Health Insurance program in 2005. Myozyme was sold in Europe and the United States after it was approved by the US government and the European Union health authority in 2006,” CNA said.
Chen’s work has resulted in saving over a thousand lives of those with Pompe Disease worldwide — also known as “acid maltase deficiency” — including 34 children in Taiwan, the CNA said.
However, not one bit of dialogue in the movie or one small note of thanks in the film’s opening or closing credits mention Chen’s name at all. He has been airbrushed out of the story, whitewashed out of the way by Hollywood moguls. Not a pretty picture.
And yet the movie itself, as Chen so graciously said, is a good one and an important one. I saw the movie the other day on a rented DVD and I agree with Chen — the film serves an important purpose in educating the public, and Ford plays his role well.
Dan Bloom is a US writer based in Taiwan.
KMT Chairwoman Cheng Li-wun’s (鄭麗文) recent visit to Beijing and her upcoming visit to Washington will serve as a high-level test of her diplomatic mettle. In Beijing, Cheng was received with symbolic gestures, a warm reception, and high-level access. In Washington, she will receive far less pomp and far sharper questions about the KMT’s vision for the future of Taiwan. Her challenge will be to persuade Washington that the KMT’s engagement with China can coexist with strong deterrence. Cheng’s April 7-12 visit to mainland China coincided with an intense period of conflict in Iran. Despite the strategic significance of Cheng’s trip,
The closure of the Strait of Hormuz has sent the vast Asian chemicals industry into a tailspin. Deprived of the likes of Qatari natural gas and Saudi Arabian oil, the region’s fertilizer and plastics plants are slowing production or even shutting down. Everywhere except China, that is. In petrochemicals, China is unique. As well as a traditional industry that uses oil and gas as feedstock, it has parallel output that relies on its abundant domestic coal. Unsurprisingly, India and other regional powers want to copy and paste the Chinese method. This would not be easy — or climate friendly. The
Indonesian President Prabowo Subianto says he knows how to fix the problems facing Indonesia. Yet his economic mismanagement and authoritarian tendencies are steering the nation toward a familiar mix of currency instability and political chaos. The world’s fourth-most populous nation risks reversing the hard-won democratic and business reforms that came after the Asian Financial Crisis in 1997. At that time, the rupiah collapsed and the political upheaval that followed forced former president Haji Mohamed Suharto from power. Prabowo’s administration is ignoring similar warning signs. That disconnect was apparent in a national address on Wednesday, when Prabowo projected the swagger that has
“Of course you can choose not to be Taiwanese, just do not stay here,” chairwoman of Taipei 101 operator Taipei Financial Center Corp Janet Chia (賈永婕) said in an online interview with local entertainer Tai Chih-yuan (邰智源), triggering intense discussion on social media, with politicians across party lines weighing in. In the interview, which was aired on May 14, Chia and Tai’s discussion over a meal in Taipei 101 covered Chia’s career change from entertainer to chairwoman and US climber Alex Honnold’s free solo climb up the Taipei 101 building. During the interview, Chia said, “Being on this land, we
RSS